Mar 30, 2025 8:33 PM
BACK TO TOP
Haleon Pakistan Limited
XD
PHARMACEUTICALS
Rs.788.19
-1.14
(-0.14%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Mar 27, 2025 1:49 PM
REG
FUT
ODL
Open
790.01
High
794.00
Low
787.00
Volume
31,456
CIRCUIT BREAKER
710.40 — 868.26
DAY RANGE
787.00 — 794.00
52-WEEK RANGE
183.22 — 975.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
789.33
VAR
12.00
HAIRCUT
22.50
P/E Ratio (TTM) **
20.15
1-Year Change *
315.27%
YTD Change *
-2.41%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.

KEY PEOPLE
Farhan Muhammad HaroonCEO
Sumru AtalayChairperson
Mashal MohammadCompany Secretary
ADDRESS

11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600

WEBSITE

www.haleon.pk

REGISTRAR

CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.

AUDITOR

M/s KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
92,261,192.66
Shares
117,054,508
Free Float
15,706,415
Free Float
13.42%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 27, 2025 Transmission of Annual Report for the Year Ended 2024 View   PDF
Feb 7, 2025Additional Information to Financial Results for the Year Ended 31 December 2024 View   PDF
Feb 6, 2025Financial Results for the Year Ended 31 December 2024 View   PDF
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 30 September 2024 View   PDF
Oct 24, 2024Financial Results for the Period Ended 30 September 2024 View   PDF
Aug 29, 2024Transmission of Half Yearly Report for the Period Ended 30 June 2024 View   PDF
Aug 22, 2024Financial Results for the Quarter Ended 30 June 2024 View   PDF
Apr 30, 2024Transmission of Quarterly Report for the Period Ended 31 March 2024 View   PDF
Apr 25, 2024Financial Results for the Quarter Ended 31 March 2024 View   PDF
Apr 8, 2024Transmission of Annual Report for the Year Ended 2023 View   PDF
DateTitleDocument
Mar 20, 2025CTC of Resolutions Passed in the Annual General Meeting 2024 View   PDF
Feb 27, 2025Notice of Annual General Meeting View   PDF
Feb 26, 2025Prior Publication of Annual General Meeting Notice View   PDF
Jan 29, 2025Notice of Board of Directors Meeting - (Q4-2024) View   PDF
Oct 16, 2024Notice of Board of Directors Meeting - (Q3-2024) View   PDF
Aug 13, 2024Notice of Board of Directors Meeting - (Q2-2024) View   PDF
Apr 26, 2024CTC of Resolutions Passed in the Annual General Meeting 2023 View   PDF
Apr 17, 2024Notice of Board of Directors Meeting - (Q1-2024) View   PDF
Apr 8, 2024Notice of Annual General Meeting View   PDF
Apr 4, 2024Prior Publication of Annual General Meeting Notice View   PDF
DateTitleDocument
Mar 27, 2025Credit of Final Cash Dividend View   PDF
Mar 26, 2025Prior Publication of Notice of Credit of Final Cash Dividend View   PDF
Mar 21, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Mar 21, 2025(Re)Appointment of Chairperson and Chief Executive Officer View   PDF
Mar 13, 2025Notice of Election of Directors View   PDF
Mar 12, 2025Material Information Made in Pakistan Centrum First Export to Kenya View   PDF
Mar 12, 2025Prior Publication of Notice of Election of Directors View   PDF
Jan 15, 2025Notice of Change in UAN View   PDF
Nov 20, 2024Presentation for Corporate Briefing Session 2024 View   PDF
Nov 19, 2024Credit of Interim Cash Dividend View   PDF
Nov 18, 2024Prior Publication of Notice of Credit of Interim Cash Dividend View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales37,205,89331,609,77627,507,21224,163,150
Profit after Taxation4,578,247995,586325,4112,134,334
EPS39.118.512.7818.23
Q3 2024Q2 2024Q1 2024Q3 2023
Sales9,754,5009,805,2137,953,6028,053,365
Profit after Taxation1,329,7841,223,459649,281314,291
EPS11.3610.455.552.68
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)34.4520.4017.4027.38
Net Profit Margin (%)12.313.151.188.83
EPS Growth (%)359.58206.12(84.75)69.11
PEG0.060.10(0.70)0.19

Payouts

DateFinancial ResultsDetailsBook Closure
February 6, 2025 4:23 PM31/12/2024(YR) 150%(F) (D) 13/03/2025 - 20/03/2025
October 25, 2024 4:20 PM30/09/2024(IIIQ)50% (i) (D) 07/11/2024 - 08/11/2024

Financial Reports